The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats

J Sex Med. 2011 Jan;8(1):97-108. doi: 10.1111/j.1743-6109.2010.01961.x.

Abstract

Introduction: Serotonin (5-HT) is an important neurotransmitter for sexual behaviors. Heterozygous (+/-) serotonin transporter (SERT) rats and SERT knockout rats (-/-) have serotonergic disturbances with significant elevations of basal extracellular 5-HT levels.

Aim: To investigate the putative role of the SERT in male sexual behavior.

Methods: After extensive sexual training, the effects of the 5-HT(1A/7) receptor agonist ± 8-OH-DPAT, the 5-HT(1A) receptor antagonist WAY100 635 and a combination of both on sexual behaviors of SERT(-/-) and SERT(+/-) knockout and wildtype (SERT(+/+) ) male Wistar rats were examined.

Main outcome measures: Male rat sexual behaviors of mounts, intromissions, and ejaculations.

Results: SERT(-/-) had lower basal ejaculation frequencies than SERT(+/-) and SERT(+/+) animals. ± 8-OH-DPAT enhanced sexual performance in all three genotypes to the same extent. WAY100635 dose-dependently inhibited sexual behavior in all three genotypes with significant dose to genotype interactions. WAY100635 exerted the strongest effects in SERT(-/-) animals. The combination of a dose range of ± 8-OH-DPAT and a selected dose of WAY100635 revealed only partial antagonism by ± 8-OH-DPAT of the sexual inhibitory effects of WAY100635.

Conclusions: Absence of the serotonin transporter reduces basal ejaculatory performance in male rats. Pharmacological experiments suggest that separate pools of 5-HT(1A) receptors regulate different aspects of sexual performance in male rats. 5-HT(7) receptors may play a minor role in the partial recovery of sexual behavior after combination of ± 8-OH-DPAT and WAY100635. The SERT(-/-) rat may be a model for chronic SSRI treatment, delayed ejaculation, anorgasmia, and/or low libido.

Publication types

  • Evaluation Study

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • Animals
  • Disease Models, Animal
  • Ejaculation / drug effects
  • Ejaculation / physiology*
  • Humans
  • Male
  • Piperazines / pharmacology
  • Pyridines / pharmacology
  • Random Allocation
  • Rats
  • Rats, Transgenic
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Serotonin Antagonists / pharmacology
  • Serotonin Plasma Membrane Transport Proteins / genetics
  • Serotonin Plasma Membrane Transport Proteins / metabolism*
  • Serotonin Receptor Agonists / pharmacology
  • Sexual Behavior / drug effects
  • Sexual Behavior / physiology*
  • Sexual Behavior, Animal
  • Sexual Dysfunction, Physiological / chemically induced*
  • Sexual Dysfunction, Physiological / physiopathology

Substances

  • Piperazines
  • Pyridines
  • Serotonin Antagonists
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Receptor Agonists
  • Serotonin Uptake Inhibitors
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
  • 8-Hydroxy-2-(di-n-propylamino)tetralin